Precision Biosciences, Inc. · NASDAQ:DTIL
Buehler Kevin exercised options for 21,000 Precision Biosciences, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 22, 2026
On May 20, 2026, Buehler Kevin (Director) exercised options for 21,000 Precision Biosciences, Inc. shares, leaving 49,137 shares. Filed May 22, 2026 (Form 4).
- Options exercised
- 21,000 shares
- Holding after
- 49,137 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Option exercise | 21,000 | 49,137 | Direct |
Source
Related
- Precision Biosciences, Inc.
- Buehler Kevin
- Precision Biosciences, Inc. shareholders
- Form 4 · Frankel Stanley · Sep 30, 2026
- Form 4 · Brown Melinda · Sep 29, 2026
- Form 4 · Germano Geno J · Sep 29, 2026
- Schedule 13G/A · Weinstein Benjamin · Aug 24, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jul 29, 2026